Anabel Sanz

Anabel has broad experience in the evaluation of technologies in life sciences, intellectual asset management, licensing, business development, and new ventures. Since 2010, she has held managerial positions in technology transfer at three research excellence centers in Spain, CNB-CSIC (Biotechnology), CNIO (Cancer), and since 2019, CRG (Genomics). Previously she worked for more than a decade in a spin-off (CropDesing) of the Flemish Institute for Biotechnology (VIB) and in the multinational company BASF. She has implemented innovation processes and successfully supported the establishment of numerous public-private research partnerships and IPR transactions. A chemist by training, she holds a Master’s in Science from the U. Wales, UK, a Ph.D. in Biology from the Autonomous University in Madrid (ES), postdoctoral experience in Spain and Belgium, and an Executive Master in Science and Technology Business from IE business school.